is glp 1 fda approved With approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins How FDA's Action Against Non-FDA-Approved
Description
Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.)

Patient awareness is at an all-time high, insurance coverage for obesity treatment is expanding, and the clinical tools available to providers have never been more effective

Adverse effects of incretin mimetics Potential adverse effects of incretin mimetics include: Hypoglycemia when taken with insulin GI distress Pancreatitis Renal insufficiency Possible risk of thyroid cancer Other non-insulin, injectable diabetes medications GIP/GLP-1 receptor co-agonists GIP/GLP-1 receptor co-agonists are used to treat type 2 diabetes only

For this reason, I generally recommend against the regular use of SSRIs in obese patients and instead would recommend a trial of Wellbutrin instead

Meal Plans Made Easy Its meal prep made easy
